ImmunityBio shows strong commercial momentum with ANKTIVA, reporting significant revenue growth and improved net loss in Q3.

Start em or sit em? Fantasy football start or sit decisions can be excruciating. While it feels great to make the right call ...

Third-quarter earnings season is almost over, but the main event is still to come, with Nvidia scheduled to release its ...

Greg McElroy painted a grim picture for Texas and its College Football Playoff chances after Tuesday's rankings.

A significant disruption of atmospheric patterns around the Arctic is expected to begin over the next few weeks, which could ...

"Thursday Night Football" expert Sam Schwartzstein joins "The Insiders" ahead of the matchup between the Buffalo Bills and ...

NFL Network Insider Tom Pelissero details the latest developments on the status of the appeal made by Cincinnati Bengals wide ...

This week on the Common Fan Podcast, we talked to Mitch Sherman of The Athletic and the Locked On Nebraska Podcast. Mitch ...

Deion Sanders discussed Julian Lewis’ growth, missed evaluations, Shedeur’s NFL start and Colorado’s AD search as Colorado ...

LLMs expose brand misalignment instantly. Discover how inconsistent messaging raises costs, kills visibility, and what brands must do to realign and win in AI search.

A variety of standout players are dealing with injuries and how they recover will impact their teams' fortunes.

2026 Outlook -- The company anticipates "double-digit adjusted earnings per share growth over the final three quarters" after a "challenging" Q1 due to sales and transitional costs, with low ...